Learn Before
[DSM-5-TR] Diagnostic Criteria of Substance/Medication-Induced Depressive Disorder
A. A prominent and persistent disturbance in mood that predominates in the clinical picture and is characterized by a depressed mood or markedly diminished interest or pleasure in all, or almost all, activities.
B. There is evidence from the history, physical examination, or laboratory findings of both (1) and (2): 1- The symptoms in Criterion A developed during or soon after the substance intoxication or withdrawal or after exposure to or withdrawal from a medication. 2- The involved substance/medication is capable of producing the symptoms in Criterion A.
C. The disturbance is not better explained by a depressive disorder that is not substance/medication-induced. Such evidence of an independent depressive disorder could include the following:
- The symptoms preceded the onset of the substance/medication use; the symptoms persist for a substantial period of time (e.g., about 1 month) after the cessation of acute withdrawal or severe intoxication; or there is other evidence suggesting the existence of an independent nonsubstance/medication-induced depressive disorder (e.g., a history of recurrent non-substance/medication- related episodes).
D. The disturbance does not occur exclusively during the course of delirium. E. The disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.
Note: This diagnosis should be made instead of a diagnosis of substance intoxication or substance withdrawal only when the symptoms in Criterion A predominate in the clinical picture and when they are sufficiently severe to warrant clinical attention.
0
1
Tags
Diagnostic and Statistical Manual (DSM)
Psychology
Social Science
Health Sciences
Empirical Science
Science
Life Science / Biology
Natural Science
Health Psychology
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
[DSM-5-TR] Diagnostic Criteria of Substance/Medication-Induced Depressive Disorder
Prevalence of Substance/Medication-Induced Depressive Disorder
Development and Course of Substance/Medication-Induced Depressive Disorder
Risk and Prognostic Factors of Substance/Medication-Induced Depressive Disorder
Related Diagnostic Issues of Substance/Medication-Induced Depressive Disorder
Diagnostic Markers of Substance/Medication-Induced Depressive Disorder
Substance/Medication-Induced Depressive Disorder Association with Suicidal Thoughts or Behavior
Differential Diagnoses to Substance/Medication-Induced Depressive Disorder
Comorbid Diagnoses to Substance/Medication-Induced Depressive Disorder
Interdisciplinary Connections & Research Related to Substance/Medication-Induced Depressive Disorder